Tengsheng Bo Pharmaceutical-B (02137.HK) announced that on September 21, 2022, the company granted a total of 20.3295 million share options to 81 share option transferees in accordance with the terms of the IPO after-sales equity plan, which is subject to acceptance by the share

2025/04/0214:08:35 hotcomm 1340

Tengsheng Boyao -B (02137.HK) announced that on September 21, 2022, the company granted a total of 20.3295 million share options to 81 share option transferees in accordance with the terms of the IPO after-sales option plan, which is subject to acceptance by the share option transferee. The exercise price of the share option is HK$6.454 per share, and the validity period is 10 years. Of these, 2.562 million share options have been granted to Director Dr. Zhi Hong.

As of the close of September 21, 2022, Tengsheng Boyao-B (02137.HK) closed at 5.64 yuan, down 4.57%, a turnover rate of 0.6%, a trading volume of 4.3625 million shares and a trading volume of 24.6703 million yuan. Investment banks mainly rating the stock on buy. In the past 90 days, a total of 1 investment bank gave buy rating , and the target average price in the past 90 days was 19.5. Everbright Securities The latest research report gave Tengsheng Bo Pharmaceutical-B buy rating, with a target price of 19.5.

Institutional rating details are shown in the table below:

Tengsheng BoPharma-BHong Kong stock market value is HK$4.275 billion, ranking 25th in the biologics II industry. The main indicators are shown in the table below:

Tengsheng Bo Pharmaceutical-B (02137.HK) announced that on September 21, 2022, the company granted a total of 20.3295 million share options to 81 share option transferees in accordance with the terms of the IPO after-sales equity plan, which is subject to acceptance by the share  - DayDayNews

and above are compiled by Securities Star based on public information and have nothing to do with the position of this site. Securities Star strives but does not guarantee the accuracy, completeness, validity, timeliness of all or part of the content of this information (including but not limited to text, video, audio, data and charts). If there are any problems, please contact us. This article is a data compilation and does not constitute any investment advice to you. Investment is risky, so please make prudent decisions.

hotcomm Category Latest News